|
|
|
|
| LEADER |
01714nam a2200397 a 4500 |
| 001 |
EBC3378464 |
| 003 |
MiAaPQ |
| 005 |
20200520144314.0 |
| 006 |
m o d | |
| 007 |
cr cn||||||||| |
| 008 |
090925s2009 dcua sb 000 0 eng d |
| 020 |
|
|
|z 9780309120883
|
| 020 |
|
|
|z 0309120888
|
| 035 |
|
|
|a (MiAaPQ)EBC3378464
|
| 035 |
|
|
|a (Au-PeEL)EBL3378464
|
| 035 |
|
|
|a (CaPaEBR)ebr10286191
|
| 035 |
|
|
|a (CaONFJC)MIL208355
|
| 035 |
|
|
|a (OCoLC)923280041
|
| 040 |
|
|
|a MiAaPQ
|c MiAaPQ
|d MiAaPQ
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a RA401.A3
|b B74 2009
|
| 245 |
0 |
0 |
|a Breakthrough business models
|h [electronic resource] :
|b drug development for rare and neglected diseases and individualized therapies : workshop summary /
|c Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.
|
| 260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c 2009.
|
| 300 |
|
|
|a 149 p. :
|b ill.
|
| 504 |
|
|
|a Includes bibliographical references (p. 104-105).
|
| 533 |
|
|
|a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
|
| 650 |
|
0 |
|a Orphan drugs
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Pharmaceutical policy
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x Design
|z United States.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Wizemann, Theresa M.
|
| 700 |
1 |
|
|a Robinson, Sally.
|
| 700 |
1 |
|
|a Giffin, Robert B.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Forum on Drug Discovery, Development, and Translation.
|
| 710 |
2 |
|
|a ProQuest (Firm)
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=3378464
|z Click to View
|
